Clinical Ink Investors

25 investors on Angel Roster list Clinical Ink in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Clinical Ink can appear together.

Investors listed
25
With verified email
48%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 Clinical Ink investors

The most complete profiles first. Showing 25 of 25.

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Dave SchulteVerified

    Venture Capital · United States

    Health CareHospitalsMedication AdherenceE-commerce

    Portfolio: IVX Health, Propeller Health, M2Gen, Aetion and 23 more

    Verified email available

  • Jennifer CarterVerified

    Venture Capital · United States

    Health CareHospitalsMedication AdherenceE-commerce

    Portfolio: IVX Health, Propeller Health, M2Gen, Aetion and 23 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Tom RodgersVerified

    Venture Capital · United States

    Health CareE-commerceWellnessWomen Founded

    Portfolio: IVX Health, Propeller Health, M2Gen, Aetion and 23 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Brian AxeVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Christina SmithVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • John BradleyVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Michael SorensenVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Patrick JordanVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Ryan WootenVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Anthony DiNoto

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Devin Rosenthal, PhD, MBA

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Guy Petrelli

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Jeff Edwards

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Jonathan Tunnicliffe

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Robert Hester, CPA

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Vern Davenport

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Clinical Ink investors are on Angel Roster?

Angel Roster lists 25 Clinical Ink investors. 12 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (25), Private Equity Firms (9) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Clinical Ink investors invest in?

Among those that list a stage, the most common are Seed (2).

Where are Clinical Ink investors based?

Most are based in the United States (25).

Which companies have Clinical Ink investors backed?

The most-backed portfolio companies among them are InformedDNA (22), Arvelle Therapeutics (13), BioCritica (13), Roivant Sciences (13) and Mesoblast (13).

How do I contact Clinical Ink investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.